Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
CA 2467958 A1 · Owner: Collins, Peter L. · Inventors: Skiadopoulos, Mario H.; Newman, Jason T.; Collins, Peter L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Recombinant human parainfluenza virus type I (HPIVI) composiitions formulations, and methods are provided. The recombinant HPIVI viruses and HPIVI chimeric and chimeric vector viruses provided according to the invention are infectious and attenuated in permissive mammalian subjects including , humans, are useful in immunogenic composition s for eliciting an immune responses against one or more PIVs, against one or more non-PIV pathogens or , against a PIV and a non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a recombinant HPIVI genome or antigenome.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.